Filter
668
Text search:
drug
trial
Featured
Recommendations
67
New Publications
107
Language
Document type
No document type
368
Guidelines
112
Studies & Reports
111
Manuals
34
Strategic & Response Plan
12
Fact sheets
12
Training Material
7
Situation Updates
6
Resource Platforms
3
Infographics
2
App
1
Countries / Regions
India
28
Global
26
South Africa
18
Western and Central Europe
15
Kenya
13
Eastern Europe
13
Africa
12
Uganda
11
Russia
10
Nigeria
8
Ghana
8
Zimbabwe
8
Tanzania
8
Zambia
7
Ukraine
7
Latin America and the Carribbean
7
Liberia
6
Ethiopia
6
Nepal
6
Rwanda
6
Malawi
6
Philippines
5
USA
4
South Sudan
4
Cambodia
4
Bangladesh
4
Brazil
4
East and Southern Africa
4
Middle East and North Africa
4
South–East Asia Region
4
Sierra Leone
3
Colombia
3
Congo, Democratic Republic of
2
Syria
2
Thailand
2
Sudan
2
Argentina
2
Hungary
2
Lesotho
2
Myanmar / Burma
2
Yemen
2
West and Central Africa
2
Asia
2
Venezuela
2
Laos
2
Tajikistan
2
Kyrgyzstan
2
Guinea
1
Senegal
1
Mali
1
Morocco
1
Cameroon
1
Germany
1
Lebanon
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
North Macedonia
1
Bolivia
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Poland
1
Southern Africa
1
Lithuania
1
Kazakhstan
1
Georgia
1
Vietnam
1
Jamaica
1
Norway
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
144
Clinical Guidelines
90
Public Health
34
Women & Child Health
34
Key Resources
11
Pharmacy & Technologies
6
Capacity Building
3
Toolboxes
HIV
109
Mental Health
105
TB
91
COVID-19
51
NTDs
39
NCDs
23
AMR
19
Pharmacy
15
Caregiver
11
Ebola & Marburg
9
Disability
8
Planetary Health
8
Refugee
7
Rapid Response
5
Malaria
5
Polio
4
Global Health Education
4
Conflict
3
Natural Hazards
3
Health Financing Toolbox
2
2.0 Rapid Response
2
Specific Hazards
1
Social Ethics
1
Essential Drug list on page 36!!
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six m
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associa
...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
This special issue on Newborn Health in Global Health Action is being launched to share the experience of how to scale up a cost-effective package of newborn care that involves families, community health workers and health facilities. The results of this community randomized
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o
...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program
...
